Global Prostate Cancer Medicine Market Professional Survey Report 2017

December 2017 | 103 pages | ID: GEC0DE46DBDEN
QYResearch

Abstracts

This report studies Prostate Cancer Medicine in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• AstraZeneca plc
• Active Biotech
• Bristol Myers-Squibb
• Teva Pharmaceuticals Industries Ltd.
• Johnson & Johnson
• Pfizer Inc.
• Bayer AG
• Abbott Laboratories
• Astellas Pharma Inc.
• Roche Holding AG

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Hormonal Therapy Drugs
• Chemotherapy Drugs
• Immunotherapy Drugs
• Target Therapy Drugs

By Application, the market can be split into

• Hospital
• Pharmacy
• Others

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Prostate Cancer Medicine Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF PROSTATE CANCER MEDICINE

1.1 Definition and Specifications of Prostate Cancer Medicine
  1.1.1 Definition of Prostate Cancer Medicine
  1.1.2 Specifications of Prostate Cancer Medicine
1.2 Classification of Prostate Cancer Medicine
  1.2.1 Hormonal Therapy Drugs
  1.2.2 Chemotherapy Drugs
  1.2.3 Immunotherapy Drugs
  1.2.4 Target Therapy Drugs
1.3 Applications of Prostate Cancer Medicine
  1.3.1 Hospital
  1.3.2 Pharmacy
  1.3.3 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF PROSTATE CANCER MEDICINE

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Prostate Cancer Medicine
2.3 Manufacturing Process Analysis of Prostate Cancer Medicine
2.4 Industry Chain Structure of Prostate Cancer Medicine

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF PROSTATE CANCER MEDICINE

3.1 Capacity and Commercial Production Date of Global Prostate Cancer Medicine Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Prostate Cancer Medicine Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Prostate Cancer Medicine Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Prostate Cancer Medicine Major Manufacturers in 2016

4 GLOBAL PROSTATE CANCER MEDICINE OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Prostate Cancer Medicine Capacity and Growth Rate Analysis
  4.2.2 2016 Prostate Cancer Medicine Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Prostate Cancer Medicine Sales and Growth Rate Analysis
  4.3.2 2016 Prostate Cancer Medicine Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Prostate Cancer Medicine Sales Price
  4.4.2 2016 Prostate Cancer Medicine Sales Price Analysis (Company Segment)

5 PROSTATE CANCER MEDICINE REGIONAL MARKET ANALYSIS

5.1 North America Prostate Cancer Medicine Market Analysis
  5.1.1 North America Prostate Cancer Medicine Market Overview
  5.1.2 North America 2012-2017E Prostate Cancer Medicine Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Prostate Cancer Medicine Sales Price Analysis
  5.1.4 North America 2016 Prostate Cancer Medicine Market Share Analysis
5.2 China Prostate Cancer Medicine Market Analysis
  5.2.1 China Prostate Cancer Medicine Market Overview
  5.2.2 China 2012-2017E Prostate Cancer Medicine Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Prostate Cancer Medicine Sales Price Analysis
  5.2.4 China 2016 Prostate Cancer Medicine Market Share Analysis
5.3 Europe Prostate Cancer Medicine Market Analysis
  5.3.1 Europe Prostate Cancer Medicine Market Overview
  5.3.2 Europe 2012-2017E Prostate Cancer Medicine Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Prostate Cancer Medicine Sales Price Analysis
  5.3.4 Europe 2016 Prostate Cancer Medicine Market Share Analysis
5.4 Southeast Asia Prostate Cancer Medicine Market Analysis
  5.4.1 Southeast Asia Prostate Cancer Medicine Market Overview
  5.4.2 Southeast Asia 2012-2017E Prostate Cancer Medicine Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Prostate Cancer Medicine Sales Price Analysis
  5.4.4 Southeast Asia 2016 Prostate Cancer Medicine Market Share Analysis
5.5 Japan Prostate Cancer Medicine Market Analysis
  5.5.1 Japan Prostate Cancer Medicine Market Overview
  5.5.2 Japan 2012-2017E Prostate Cancer Medicine Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Prostate Cancer Medicine Sales Price Analysis
  5.5.4 Japan 2016 Prostate Cancer Medicine Market Share Analysis
5.6 India Prostate Cancer Medicine Market Analysis
  5.6.1 India Prostate Cancer Medicine Market Overview
  5.6.2 India 2012-2017E Prostate Cancer Medicine Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Prostate Cancer Medicine Sales Price Analysis
  5.6.4 India 2016 Prostate Cancer Medicine Market Share Analysis

6 GLOBAL 2012-2017E PROSTATE CANCER MEDICINE SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Prostate Cancer Medicine Sales by Type
6.2 Different Types of Prostate Cancer Medicine Product Interview Price Analysis
6.3 Different Types of Prostate Cancer Medicine Product Driving Factors Analysis
  6.3.1 Hormonal Therapy Drugs of Prostate Cancer Medicine Growth Driving Factor Analysis
  6.3.2 Chemotherapy Drugs of Prostate Cancer Medicine Growth Driving Factor Analysis
  6.3.3 Immunotherapy Drugs of Prostate Cancer Medicine Growth Driving Factor Analysis
  6.3.4 Target Therapy Drugs of Prostate Cancer Medicine Growth Driving Factor Analysis

7 GLOBAL 2012-2017E PROSTATE CANCER MEDICINE SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Prostate Cancer Medicine Consumption by Application
7.2 Different Application of Prostate Cancer Medicine Product Interview Price Analysis
7.3 Different Application of Prostate Cancer Medicine Product Driving Factors Analysis
  7.3.1 Hospital of Prostate Cancer Medicine Growth Driving Factor Analysis
  7.3.2 Pharmacy of Prostate Cancer Medicine Growth Driving Factor Analysis
  7.3.3 Others of Prostate Cancer Medicine Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF PROSTATE CANCER MEDICINE

8.1 AstraZeneca plc
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 AstraZeneca plc 2016 Prostate Cancer Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 AstraZeneca plc 2016 Prostate Cancer Medicine Business Region Distribution Analysis
8.2 Active Biotech
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Active Biotech 2016 Prostate Cancer Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Active Biotech 2016 Prostate Cancer Medicine Business Region Distribution Analysis
8.3 Bristol Myers-Squibb
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Bristol Myers-Squibb 2016 Prostate Cancer Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Bristol Myers-Squibb 2016 Prostate Cancer Medicine Business Region Distribution Analysis
8.4 Teva Pharmaceuticals Industries Ltd.
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Teva Pharmaceuticals Industries Ltd. 2016 Prostate Cancer Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Teva Pharmaceuticals Industries Ltd. 2016 Prostate Cancer Medicine Business Region Distribution Analysis
8.5 Johnson & Johnson
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Johnson & Johnson 2016 Prostate Cancer Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Johnson & Johnson 2016 Prostate Cancer Medicine Business Region Distribution Analysis
8.6 Pfizer Inc.
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Pfizer Inc. 2016 Prostate Cancer Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Pfizer Inc. 2016 Prostate Cancer Medicine Business Region Distribution Analysis
8.7 Bayer AG
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Bayer AG 2016 Prostate Cancer Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Bayer AG 2016 Prostate Cancer Medicine Business Region Distribution Analysis
8.8 Abbott Laboratories
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Abbott Laboratories 2016 Prostate Cancer Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Abbott Laboratories 2016 Prostate Cancer Medicine Business Region Distribution Analysis
8.9 Astellas Pharma Inc.
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Astellas Pharma Inc. 2016 Prostate Cancer Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Astellas Pharma Inc. 2016 Prostate Cancer Medicine Business Region Distribution Analysis
8.10 Roche Holding AG
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Roche Holding AG 2016 Prostate Cancer Medicine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Roche Holding AG 2016 Prostate Cancer Medicine Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF PROSTATE CANCER MEDICINE MARKET

9.1 Global Prostate Cancer Medicine Market Trend Analysis
  9.1.1 Global 2017-2022 Prostate Cancer Medicine Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Prostate Cancer Medicine Sales Price Forecast
9.2 Prostate Cancer Medicine Regional Market Trend
  9.2.1 North America 2017-2022 Prostate Cancer Medicine Consumption Forecast
  9.2.2 China 2017-2022 Prostate Cancer Medicine Consumption Forecast
  9.2.3 Europe 2017-2022 Prostate Cancer Medicine Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Prostate Cancer Medicine Consumption Forecast
  9.2.5 Japan 2017-2022 Prostate Cancer Medicine Consumption Forecast
  9.2.6 India 2017-2022 Prostate Cancer Medicine Consumption Forecast
9.3 Prostate Cancer Medicine Market Trend (Product Type)
9.4 Prostate Cancer Medicine Market Trend (Application)

10 PROSTATE CANCER MEDICINE MARKETING TYPE ANALYSIS

10.1 Prostate Cancer Medicine Regional Marketing Type Analysis
10.2 Prostate Cancer Medicine International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Prostate Cancer Medicine by Region
10.4 Prostate Cancer Medicine Supply Chain Analysis

11 CONSUMERS ANALYSIS OF PROSTATE CANCER MEDICINE

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL PROSTATE CANCER MEDICINE MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Prostate Cancer Medicine
Table Product Specifications of Prostate Cancer Medicine
Table Classification of Prostate Cancer Medicine
Figure Global Production Market Share of Prostate Cancer Medicine by Type in 2016
Figure Hormonal Therapy Drugs Picture
Table Major Manufacturers of Hormonal Therapy Drugs
Figure Chemotherapy Drugs Picture
Table Major Manufacturers of Chemotherapy Drugs
Figure Immunotherapy Drugs Picture
Table Major Manufacturers of Immunotherapy Drugs
Figure Target Therapy Drugs Picture
Table Major Manufacturers of Target Therapy Drugs
Table Applications of Prostate Cancer Medicine
Figure Global Consumption Volume Market Share of Prostate Cancer Medicine by Application in 2016
Figure Hospital Examples
Table Major Consumers in Hospital
Figure Pharmacy Examples
Table Major Consumers in Pharmacy
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Prostate Cancer Medicine by Regions
Figure North America Prostate Cancer Medicine Market Size (Million USD) (2012-2022)
Figure China Prostate Cancer Medicine Market Size (Million USD) (2012-2022)
Figure Europe Prostate Cancer Medicine Market Size (Million USD) (2012-2022)
Figure Southeast Asia Prostate Cancer Medicine Market Size (Million USD) (2012-2022)
Figure Japan Prostate Cancer Medicine Market Size (Million USD) (2012-2022)
Figure India Prostate Cancer Medicine Market Size (Million USD) (2012-2022)
Table Prostate Cancer Medicine Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Prostate Cancer Medicine in 2016
Figure Manufacturing Process Analysis of Prostate Cancer Medicine
Figure Industry Chain Structure of Prostate Cancer Medicine
Table Capacity and Commercial Production Date of Global Prostate Cancer Medicine Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Prostate Cancer Medicine Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Prostate Cancer Medicine Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Prostate Cancer Medicine Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Prostate Cancer Medicine 2012-2017
Figure Global 2012-2017E Prostate Cancer Medicine Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Prostate Cancer Medicine Market Size (Value) and Growth Rate
Table 2012-2017E Global Prostate Cancer Medicine Capacity and Growth Rate
Table 2016 Global Prostate Cancer Medicine Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Prostate Cancer Medicine Sales (K Units) and Growth Rate
Table 2016 Global Prostate Cancer Medicine Sales (K Units) List (Company Segment)
Table 2012-2017E Global Prostate Cancer Medicine Sales Price (USD/Unit)
Table 2016 Global Prostate Cancer Medicine Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Prostate Cancer Medicine 2012-2017E
Figure North America 2012-2017E Prostate Cancer Medicine Sales Price (USD/Unit)
Figure North America 2016 Prostate Cancer Medicine Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Prostate Cancer Medicine 2012-2017E
Figure China 2012-2017E Prostate Cancer Medicine Sales Price (USD/Unit)
Figure China 2016 Prostate Cancer Medicine Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Prostate Cancer Medicine 2012-2017E
Figure Europe 2012-2017E Prostate Cancer Medicine Sales Price (USD/Unit)
Figure Europe 2016 Prostate Cancer Medicine Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Prostate Cancer Medicine 2012-2017E
Figure Southeast Asia 2012-2017E Prostate Cancer Medicine Sales Price (USD/Unit)
Figure Southeast Asia 2016 Prostate Cancer Medicine Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Prostate Cancer Medicine 2012-2017E
Figure Japan 2012-2017E Prostate Cancer Medicine Sales Price (USD/Unit)
Figure Japan 2016 Prostate Cancer Medicine Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Prostate Cancer Medicine 2012-2017E
Figure India 2012-2017E Prostate Cancer Medicine Sales Price (USD/Unit)
Figure India 2016 Prostate Cancer Medicine Sales Market Share
Table Global 2012-2017E Prostate Cancer Medicine Sales (K Units) by Type
Table Different Types Prostate Cancer Medicine Product Interview Price
Table Global 2012-2017E Prostate Cancer Medicine Sales (K Units) by Application
Table Different Application Prostate Cancer Medicine Product Interview Price
Table AstraZeneca plc Information List
Table Product A Overview
Table Product B Overview
Table 2016 AstraZeneca plc Prostate Cancer Medicine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 AstraZeneca plc Prostate Cancer Medicine Business Region Distribution
Table Active Biotech Information List
Table Product A Overview
Table Product B Overview
Table 2016 Active Biotech Prostate Cancer Medicine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Active Biotech Prostate Cancer Medicine Business Region Distribution
Table Bristol Myers-Squibb Information List
Table Product A Overview
Table Product B Overview
Table 2015 Bristol Myers-Squibb Prostate Cancer Medicine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Bristol Myers-Squibb Prostate Cancer Medicine Business Region Distribution
Table Teva Pharmaceuticals Industries Ltd. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Business Region Distribution
Table Johnson & Johnson Information List
Table Product A Overview
Table Product B Overview
Table 2016 Johnson & Johnson Prostate Cancer Medicine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Johnson & Johnson Prostate Cancer Medicine Business Region Distribution
Table Pfizer Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer Inc. Prostate Cancer Medicine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Pfizer Inc. Prostate Cancer Medicine Business Region Distribution
Table Bayer AG Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bayer AG Prostate Cancer Medicine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Bayer AG Prostate Cancer Medicine Business Region Distribution
Table Abbott Laboratories Information List
Table Product A Overview
Table Product B Overview
Table 2016 Abbott Laboratories Prostate Cancer Medicine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Abbott Laboratories Prostate Cancer Medicine Business Region Distribution
Table Astellas Pharma Inc. Information List
Table Product A Overview
Table Product B Overview
Table 2016 Astellas Pharma Inc. Prostate Cancer Medicine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Astellas Pharma Inc. Prostate Cancer Medicine Business Region Distribution
Table Roche Holding AG Information List
Table Product A Overview
Table Product B Overview
Table 2016 Roche Holding AG Prostate Cancer Medicine Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Roche Holding AG Prostate Cancer Medicine Business Region Distribution
Figure Global 2017-2022 Prostate Cancer Medicine Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Prostate Cancer Medicine Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Prostate Cancer Medicine Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Prostate Cancer Medicine Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Prostate Cancer Medicine Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Prostate Cancer Medicine Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Prostate Cancer Medicine Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Prostate Cancer Medicine Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Prostate Cancer Medicine Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Prostate Cancer Medicine by Type 2017-2022
Table Global Consumption Volume (K Units) of Prostate Cancer Medicine by Application 2017-2022
Table Traders or Distributors with Contact Information of Prostate Cancer Medicine by Region